149806-52-0

Basic information

• Product Name: 1-(5-Bromo-2-pyridinyl)-4-piperidinol
• Synonyms: 1-(5-Bromo-2-pyridinyl)-4-piperidinol;1-(5-broMopyridin-2-yl)piperidin-4-ol;5'-BroMo-3,4,5,6-tetrahydro-2H-[1,2']bipyridinyl-4-ol
• CAS NO: 149806-52-0
• Molecular Formula: C₁₀H₁₃BrN₂O
• Molecular Weight: 257.14
• Product Categories: pharmacetical
• Mol File: 149806-52-0.mol

Chemical Properties

• Boiling Point: 391°Cat760mmHg
• Flash Point: 190.3°C
• Appearance: /
• Density: 1.529g/cm³
• Vapor Pressure: 0mmHg at 25°C
• Refractive Index: 1.612
• PKA: 14.67±0.20(Predicted)
• CAS DataBase Reference: 1-(5-Bromo-2-pyridinyl)-4-piperidinol(CAS DataBase Reference)
• NIST Chemistry Reference: 1-(5-Bromo-2-pyridinyl)-4-piperidinol(149806-52-0)
• EPA Substance Registry System: 1-(5-Bromo-2-pyridinyl)-4-piperidinol(149806-52-0)

Safety Data

• HazardClass: IRRITANT
• Hazardous Substances Data: 149806-52-0(Hazardous Substances Data)

Usage

Uses

Used in Organic Synthesis:
1-(5-Bromo-2-pyridinyl)-4-piperidinol is used as a building block in organic synthesis for the creation of a variety of complex organic molecules. Its unique structure allows it to serve as a key intermediate in the synthesis of pharmaceuticals and other biologically active compounds.
Used in Pharmaceutical Industry:
In the pharmaceutical industry, 1-(5-Bromo-2-pyridinyl)-4-piperidinol is utilized as a precursor in the development of new drugs. Its structure and properties make it a candidate for research and development, potentially leading to the discovery of novel therapeutic agents.
Used in Agrochemicals:
1-(5-Bromo-2-pyridinyl)-4-piperidinol also finds application in the agrochemical sector, where it may be employed in the synthesis of pesticides or other agrochemical products, contributing to the development of more effective and targeted solutions for agricultural challenges.
Further studies are essential to fully explore the potential uses and effects of 1-(5-Bromo-2-pyridinyl)-4-piperidinol, ensuring that its integration into various industries is both safe and beneficial.

InChI:InChI=1/C10H13BrN2O/c11-8-1-2-10(12-7-8)13-5-3-9(14)4-6-13/h1-2,7,9,14H,3-6H2

Upstream product

• 5382-16-1 4-HYDROXYPIPERIDINE 
• 624-28-2 2,5-dibromopyridine 
• 53939-30-3 5-bromo-2-chloropyridine 

Downstream Products

• 1020658-43-8 5-bromo-2-(4-{[2-(trifluoromethyl)phenyl]}-1-piperidinyl)pyridine 

Relevant articles and documents

1,4-BENZODIAZEPINONE COMPOUNDS AND THEIR USE IN TREATING CANCER

The invention provides a family of 1,4-benzodiazepinone compounds and methods for their use as therapeutic agents in treating cancer. Pharmaceutical compositions and methods of making the 1,4-benzodiazepinone compounds are provided.

AZACYCLOALKANE DERIVATIVES AS INHIBITORS OF STEAROYL-COENZYME A DELTA-9 DESATURASE

Azacycloalkane derivatives of structural formula (I) are selective inhibitors of stearoyl-coenzyme A delta-9 desaturase (SCD1) relative to other known stearoyl-coenzyme A desaturases. The compounds of the present invention are useful for the prevention and treatment of conditions related to abnormal lipid synthesis and metabolism, including cardiovascular disease, such as atherosclerosis; obesity; diabetes; neurological disease; metabolic syndrome; insulin resistance; and liver steatosis.

NOVEL MCH RECEPTOR ANTAGONISTS

The present invention relates to a melanin concentrating hormone antagonist compound of formula (I): wherein R1, Ra, Rb, R2, L1, R3, R4 and R5 are as defined, or a pharmaceutically acceptable salt, enantiomer, diastereomer or mixture of diasteromers thereof useful in the treatment, obesity and related diseases.

FUSED-ARYL AND HETEROARYL DERIVATIVES AS MODULATORS OF METABOLISM AND THE PROPHYLAXIS AND TREATMENT OF DISORDERS RELATED THERETO

The present invention relates to certain fused aryl and heteroaryl derivatives of Formula (I) that are modulators of metabolism. Accordingly, compounds of the present invention are useful in the prophylaxis or treatment of metabolic disorders and complica

3-cyanoquinolines, 3-cyano-1,6-naphthyridines, and 3-cyano-1,7-naphthyridines as protein kinase inhibitors

This invention provides compounds of Formula (I), having the structure where T, Z, X, A, R1, R2a, R2b, R2c, R3, R4, and n are defined herein, or a pharmaceutically acceptable salt thereof which are useful as antineoplastic agents and in the treatment of osteoporosis and polycystic kidney disease.